Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

Brent A. Neuschwander-Tetri, Elizabeth M. Brunt, Kent R. Wehmeier, Dana Oliver, Bruce R. Bacon

Research output: Contribution to journalArticlepeer-review

713 Scopus citations

Fingerprint

Dive into the research topics of 'Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone'. Together they form a unique fingerprint.

Medicine & Life Sciences